Latest Breaking News On - All patients with lung - Page 1 : comparemela.com

/PRNewswire/ Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage targeted oncology company today announced the presentation of new clinical research.

United statesCharles baumJoshuak sabariAlexanderi spiraAmerican society of clinical oncologyPrnewswire mirati therapeutics incDrug administrationMirati therapeutics incExchange commissionAccess programVirtual investor eventClinical oncologyAnnual meetingMirati therapeuticsNew drug applicationAccelerated approval